Brief report

Ahead-of-Print

Passenger lymphocyte syndrome after living-donor kidney transplantation with minor ABO incompatibility: a case report

Authors

Key words: ABO incompatibility, Passenger lymphocyte syndrome, Kidney transplantation, Plasma Exchange, Direct antiglobulin test
Publication Date: 2026-02-11

Abstract

Passenger lymphocyte syndrome (PLS) is an uncommon, immune-mediated hemolytic disorder that may develop after solid organ or hematopoietic stem cell transplantation when minor ABO incompatibility exists between donor and recipient. It is caused by donor-derived viable B lymphocytes producing antibodies against recipient erythrocyte antigens.

We describe a 28-year-old female (recipient blood group A RhD-positive) who underwent living-donor kidney transplantation from her father (donor group O RhD-positive). Two weeks post-transplant, she presented with fatigue, right shoulder and scapular pain. Laboratory evaluation demonstrated severe normocytic anemia (hemoglobin 49 g/L), elevated lactate dehydrogenase and bilirubin levels, undetectable haptoglobin, and a strongly positive direct antiglobulin test (IgG and C3d). Elution studies identified anti-A antibodies bound to red blood cells, suggestive of PLS. Imaging excluded bleeding but revealed thrombosis of the right internal jugular and brachiocephalic veins. Management included plasma-exchange (PEX), high-dose corticosteroids, and transfusion of irradiated donor-type (group O RhD-positive) red cells. The patient showed progressive hematologic recovery with normalization of hemolytic indices and preserved graft function at hospital discharge.

PLS should be considered in the differential diagnosis of acute hemolytic anemia occurring within the first three weeks after transplantation involving minor ABO mismatch. Early recognition through direct antiglobulin testing (DAT) is essential to guide transfusion strategy and immunomodulatory therapy. Combined PEX and corticosteroid treatment effectively reduced antibody-mediated hemolysis. Routine post-transplant DAT screening may facilitate prompt diagnosis and improve clinical outcomes in renal transplant recipients.

References

Downloads

Authors

Alessandra Sandini Transfusion Medicine Department, ULSS 8 Berica, Vicenza, Italy

Teresa Giulia Da Molin Transfusion Medicine Department, ULSS 8 Berica, Vicenza, Italy

Gabriella Errigo Transfusion Medicine Department, ULSS 8 Berica, Vicenza, Italy

Barbara Sartori Transfusion Medicine Department, ULSS 8 Berica, Vicenza, Italy

Cinzia Ongaro Transfusion Medicine Department, ULSS 8 Berica, Vicenza, Italy

Monica Castelli Transfusion Medicine Department, ULSS 8 Berica, Vicenza, Italy

Manuela Rigno Transfusion Medicine Department, ULSS 8 Berica, Vicenza, Italy

Davide Facchinelli Hematology Department, ULSS 8 Berica, Vicenza, Italy

Fiorella Gastaldon Department of Nephrology, Dialysis and Transplantation, ULSS 8 Berica, Vicenza, Italy

Francesco Fiorin Transfusion Medicine Department, ULSS 8 Berica, Vicenza, Italy

  • Abstract viewed - 108 times
  • pdf downloaded - 0 times